Zubrod Memorial Lecture
Annual Zubrod Memorial Lecture & Cancer Research Poster Session
The 13th Annual Zubrod Memorial Lecture & Sylvester Cancer Research Poster Session held in honor of its founding director, Charles Gordon Zubrod, M.D., will take place on Friday, May 18, 2012. The 2012 Distinguished Lecturer Ronald Levy, M.D., Robert K. Summy and Helen K. Summy Professor of Medicine, Chief, Division of Oncology, Stanford University School of Medicine, will present a lecture entitled “Immunotherapy of Lymphoma.”
Each year, the Zubrod Memorial Lecture is held in association with the annual cancer research poster competition. The goal of this event is to provide a competitive stimulus for creativity in translational cancer research and an opportunity for the exchange of ideas. Faculty, clinical fellows, postdoctoral trainees and graduate students are encouraged to participate by attending the lecture, presenting a poster, and by viewing the posters of their colleagues. This year, more than 70 posters have been submitted.
Past Zubrod Memorial Distinguished Guest Lecturers
2011: “Lessons from Death Signaling”
Vishva Dixit, M.D
2010: “Modeling Human Cancer in the Mouse”
Mario R. Capecchi, Ph.D.
2009: “Nuclear Receptor Coactivators: ‘Master Genes’ and Targets of Disease”
Bert O’Malley, M.D.
2008: “Modeling Cancer in the Mouse”
Tyler Jacks, Ph.D.
2007: “Taxol, Tubulin, and Tumors: Challenges in the New Era of Chemotherapy”
Susan Band Horwitz, Ph.D.
2006: “Lessons from Antiangiogenic Therapy and Other Diseases”
Judah Folkman, M.D.
2005: Allogeneic Stem Cell Transplantation 1965-2005: “Advancing Knowledge, Saving Lives” Rainer F. Storb, M.D.
2004: “From Sarcoma Growth Factor to TGF-beta Targeted
Therapeutics in Human Neoplasia” Carlos L. Arteaga, M.D.
2003: “The Control of Immunity and Tolerance by Dendritic Cells”
Ralph M. Steinman, M.D.
2002: “Mitochondrial Gateway to Apoptosis” Stanley Korsmeyer, M.D.
2001: “Does Apoptosis Play a Role in the Etiology or Treatment of Cancer?”
Craig B. Thompson, M.D.
2000: “The Development of Cancer Vaccines”
Steven A. Rosenberg, M.D., Ph.D.